Article
Relevance of RH variants in transfusion of sickle cell patients. Noizat-Pirenne F, Tournamille C. Transfus Clin Biol, 2011. [Citation]
Annotations by Allele
- DOL - partly characterized or subtypes not separated: AbSpecificity (review)
- RHD*1136T (DAU0): AbSpecificity
- RHD*186T,410T,455C,1048C (DIVa): RH1
- RHD*186T,410T,455C,1048C (DIVa): AbSpecificity
- RHD*186T,410T,455C,1048C (DIVa): Prevalence
- RHD*186T,410T,455C,1048C (DIVa): AbSpecificity (review)
- RHD*186T,410T,455C,602G,667G,819A (DIIIa): AbSpecificity (review)
- RHD*186T,410T,455C,602G,667G,819A (DIIIa): Prevalence
- RHD*186T,410T,455C,602G,667G,819A (DIIIa): RH1
- RHD*209A,998A,1136T (DAU2): RH1
- RHD*209A,998A,1136T (DAU2): Prevalence
- RHD*48C,602G,667G,819A (weak D type 4.1, DAR4): AbSpecificity
- RHD*602G,667G,744T,1025C (weak D type 4.2.3, DAR1.03): AbSpecificity
- RHD*602G,667G,744T,1025C (weak D type 4.2.3, DAR1.03): AbSpecificity (review)
- RHD*602G,667G,744T,957A,1025C (weak D type 4.2.2, DAR1.02): AbSpecificity (review)
- RHD*602G,667G,957A,1025C (weak D type 4.2.1, DAR1.01): AbSpecificity (review)
- RHD*667G,697C,1136T (DAU5): RH1
- RHD*667G,697C,1136T (DAU5): AbSpecificity
- RHD*667G,697C,1136T (DAU5): Prevalence
- RHD*697A (DV type 5, DHK): Prevalence
- RHD*697A,1136T (DAU4): RH1
- RHD*697A,1136T (DAU4): Prevalence
- RHD*697A,1136T (DAU4): AbSpecificity (review)
- RHD*835A,1136T (DAU3): AbSpecificity
- RHD*841C: AbSpecificity
- RHD*851T (DLO, RHD*36): RH1
- RHD*851T (DLO, RHD*36): Prevalence
- standard RHD (RHD*01): AbSpecificity
- weak D type 4 - partly characterized or subtypes not separated: RH1
- weak D type 4 - partly characterized or subtypes not separated: Prevalence
- weak D type 4.2.x (DAR) - partly characterized or subtypes not separated: RH1
- weak D type 4.2.x (DAR) - partly characterized or subtypes not separated: Prevalence